Loading…
Based on limited metadata, this FDA Warning Letter issued to PT Mitra T.N. on January 9, 2018, involves a company with unspecified product classification listed as "Other." Without access to the full letter text or a detailed subject line, the specific nature of the regulatory violations cannot be determined from the available information. The issuing office is not identified in the metadata, which limits clarity on the exact regulatory pathway and product category involved. Additional documentation would be needed to assess the full scope and details of the compliance concerns raised.